Cleared Traditional

K924214 - ECLIPSE 2100(TM) MODEL 32

K924214 is an FDA 510(k) clearance for ECLIPSE 2100(TM) MODEL 32, manufactured by Cardiogenes. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K924214 · Cardiogenes · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1992
Decision
111d
Days
Class 2
Risk

K924214 is an FDA 510(k) clearance for the ECLIPSE 2100(TM) MODEL 32. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Cardiogenes (Palo Alto, US). The FDA issued a Cleared decision on November 16, 1992 after a review of 111 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardiogenes devices

FDA 510(k) Submission Details - K924214

510(k) Number K924214 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 1992
Decision Date November 16, 1992
Days to Decision 111 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 115d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1639
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K924214.
INCISOR I PULSED ND:YAG LASER SYSTEM
K922901 · Buckman Co., Inc. · Nov 1992
MEGABEAM
K923953 · Ceram Optec, Inc. · Nov 1992
CLARUS MODELS 1100, 1101, 1102, 1103 LASER DISC
K922881 · Clarus Medical Systems, Inc. · Nov 1992
ALCON(R) FX2(TM) PHOTOCOAGULATOR
K914334 · Alcon Laboratories · Nov 1992
ZEISS VISULAS ARGON LASER
K923341 · Carl Zeiss, Inc. · Oct 1992
CYNOSURE PHOTOGENICA T TATTOO REMOVAL LASER
K923683 · Cynosure, Inc. · Oct 1992